IRIS

Sfoglia per Rivista  

opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 18 a 37 di 44
Titolo Data di pubblicazione Autore(i) File
In-bag morcellation for presumed myoma retrieval at laparoscopy 1-gen-2014 Bogani, Giorgio; Serati, Maurizio; Uccella, Silvia; Ghezzi, Fabio
Insulin-Like Growth Factor-1 Receptor and Phosphorylated AKT-Serine 473 Expression in 132 Resected Thymomas and Thymic Carcinomas 1-gen-2010 Zucali, PAOLO ANDREA; Petrini, I; Lorenzi, E; Merino, M; Cao, L; Di Tommaso, L; Lee, H S; Incarbone, M; Walter, B A; Simonelli, M; Roncalli, M; Santoro, A; Giaccone, G; RI Lee, H S
Interferon-beta can induce progesterone receptors in human endometrial adenocarcinoma 1-gen-1996 Codegoni, Am; Landoni, F; Lomonico, S; Losa, G; Mangioni, C; Taverna, M; Lucchini, V; D'Incalci, M
INTRAOPERATIVE RADIATION-THERAPY ADJUVANT TO RESECTION IN THE TREATMENT OF PANCREATIC-CANCER 1-gen-1994 Zerbi, A; Fossati, V; Parolini, D; Carlucci, M; Balzano, G; Bordogna, G; Staudacher, C; Dicarlo, V
Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma 1-gen-1998 Livraghi, T.; Benedini, V.; Lazzaroni, S.; Meloni, F.; Torzilli, G.; Vettori, C.
Micro-ultrasound may significantly reduce the proportion of unnecessary prostate biopsies in patients with PI-RADS 3 lesions 1-gen-2023 Avolio, Pier Paolo; Lazzeri, Massimo; Buffi, Nicolò Maria; Lughezzani, Giovanni
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer 1-gen-2007 Zlobec, I; Minoo, P; Baumhoer, D; Baker, K; Terracciano, L; Jass, Jr; Lugli, A
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 1-gen-2011 Guidetti, A.; Carlo Stella, C.; Ruella, M.; Miceli, R.; Devizzi, L.; Locatelli, S. L.; Giacomini, A.; Testi, A.; Buttiglieri, S.; Risso, A.; Mariani, L.; Di Nicola, M.; Passera, R.; Tarella, C.; Gianni, A.
Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery 1-gen-2000 Pedrazzoli, P; Lanza, A; Battaglia, M; Da Prada, Ga; Zambelli, A; Perotti, C; Ponchio, L; Salvaneschi, L; della Cuna, Gr
Pembrolizumab for the treatment of programmed Death-Ligand-1-Positive advanced carcinoid or pancreatic neuroendocrine tumors: results from the KEYNOTE-028 Study 1-gen-2020 Mehnert, J M; Bergsland, E; O’Neil, B H; Santoro, A; Schellens, J H M; Cohen, R B; Doi, T; Ott, P A; Pishvaian, M J; Puzanov, I; Aung, K L; Hsu, C; Le Tourneau, C; Hollebecque, A; Elez, E; Tamura, K; Gould, M; Yang, P; Stein, K; Piha-Paul, S A
Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis : a study on 207 patients 1-gen-1992 Livraghi, T.; Bolondi, L.; Lazzaroni, S.; Marin, G.; Morabito, A.; Rapaccini, G. L.; Salmi, A.; Torzilli, G.
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group 1-gen-2020 Grosso, Federica; D'Ambrosio, Lorenzo; Zucchetti, Massimo; Ibrahim, Toni; Tamberi, Stefano; Matteo, Cristina; Rulli, Eliana; Comandini, Danila; Palmerini, Emanuela; Baldi, Giacomo Giulio; Decensi, Andrea; Bergaglio, Marina; Marra, Domenico; Marchesi, Emanuela; Siri, Giacomo; D'Incalci, Maurizio; Grignani, Giovanni
A Population-Based Competing-Risks Analysis of the Survival of Patients Treated With Radical Cystectomy for Bladder Cancer 1-gen-2011 Lughezzani, G; Sun, M; Shariat, Sf; Budaus, L; Thuret, R; Jeldres, C; Liberman, D; Montorsi, F; Perrotte, P; Karakiewicz, Pi
Prediction of Sexual Function After Radical Prostatectomy 1-gen-2009 Briganti, A; Capitanio, U; Chun, Fkh; Karakiewicz, Pi; Salonia, A; Bianchi, M; Cestari, A; Guazzoni, G; Rigatti, P; Montorsi, F
Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer - A systematic review 1-gen-2007 de Geus-Oei, Lf; van der Heijden, Hfm; Corstens, Fhm; Oyen, W
Pretargeted Radioimmunoscintigraphy in Patients With Primary Colorectal Cancer Using a Bispecific Anticarcinoembryonic Antigen CEA X Anti-Di-Diethylenetriaminepentaacetic Acid F(ab ')(2) Antibody 1-gen-2010 Aarts, F; Boerman, Oc; Sharkey, Rm; Hendriks, T; Chang, Ch; Mcbride, Wj; Bleichrodt, Rp; Oyen, W; Goldenberg, Dm
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation 1-gen-2005 Peccatori, J; Barkholt, L; Demirer, T; Sormani, Mp; Bruzzi, P; Ciceri, F; Zambelli, A; Da Prada, Ga; Pedrazzoli, P; Siena, S; Massenkeil, G; Martino, R; Lenhoff, S; Corradini, P; Rosti, G; Ringden, O; Bregni, M; Niederwieser, D
Prognostic Significance of Lymph Node Invasion in Patients With Metastatic Renal Cell Carcinoma A Population-Based Perspective 1-gen-2009 Lughezzani, G; Capitanio, U; Jeldres, C; Isbarn, H; Shariat, Sf; Arjane, P; Widmer, H; Perrotte, P; Montorsi, F; Karakiewicz, Pi
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer 1-gen-2012 Livi, L; Meattini, I; Saieva, C; Franzese, C; Di Cataldo, V; Greto, D; Franceschini, D; Scotti, V; Bonomo, P; Nori, J; Sanchez, L; Vezzosi, V; Bianchi, S; Cataliotti, L; Biti, G
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy 1-gen-2022 Perrino, Matteo; De Pas, Tommaso; Bozzarelli, Silvia; Giordano, Laura; De Vincenzo, Fabio; Conforti, Fabio; Digiacomo, Nunzio; Cordua, Nadia; D'Antonio, Federica; Borea, Federica; Santoro, Armando; Zucali, Paolo Andrea
Mostrati risultati da 18 a 37 di 44
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile